Literature DB >> 3027630

Cough with angiotensin converting-enzyme inhibitors.

S Hood, M G Nicholls, N L Gilchrist.   

Abstract

Since there are isolated case reports linking cough with angiotensin converting-enzyme (ACE) inhibitor treatment, we reviewed the case notes of patients attending a hypertension outpatient clinic. Of 126 patients, 37 were on medications other than ACE inhibitors, and none complained of cough. In contrast, 12 of 89 patients receiving an ACE inhibitor had noted cough. The symptoms remained when one ACE inhibitor was substituted for another, but disappeared when the drug was withdrawn. Cough was sufficiently irritating to require cessation of treatment in two patients. We conclude that cough is not uncommon during treatment with ACE inhibitors.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3027630

Source DB:  PubMed          Journal:  N Z Med J        ISSN: 0028-8446


  11 in total

1.  Bronchial hyperreactivity in patients who cough after receiving angiotensin converting enzyme inhibitors.

Authors:  C E Bucknall; J B Neilly; R Carter; R D Stevenson; P F Semple
Journal:  Br Med J (Clin Res Ed)       Date:  1988-01-09

Review 2.  Molecular biology of angiotensin receptors and their role in human cardiovascular disease.

Authors:  V Regitz-Zagrosek; M Neuss; J Holzmeister; C Warnecke; E Fleck
Journal:  J Mol Med (Berl)       Date:  1996-05       Impact factor: 4.599

3.  Cough and enalapril: assessment by spontaneous reporting and visual analogue scale under double-blind conditions.

Authors:  W W Yeo; D Maclean; P J Richardson; L E Ramsay
Journal:  Br J Clin Pharmacol       Date:  1991-03       Impact factor: 4.335

4.  Cough and angiotensin converting enzyme inhibition.

Authors:  K E Berkin; S G Ball
Journal:  Br Med J (Clin Res Ed)       Date:  1988-05-07

5.  Increased cough reflex associated with angiotensin converting enzyme inhibitor cough.

Authors:  R W Fuller; N B Choudry
Journal:  Br Med J (Clin Res Ed)       Date:  1987-10-24

6.  A high incidence of cough in Chinese subjects treated with angiotensin converting enzyme inhibitors.

Authors:  W K Chan; T Y Chan; W K Luk; V K Leung; T H Li; J A Critchley
Journal:  Eur J Clin Pharmacol       Date:  1993       Impact factor: 2.953

7.  Bronchospasm and cough as adverse reactions to the ACE inhibitors captopril, enalapril and lisinopril. A controlled retrospective cohort study.

Authors:  R Wood
Journal:  Br J Clin Pharmacol       Date:  1995-03       Impact factor: 4.335

8.  Once vs twice daily administration of a fixed combination of captopril plus hydrochlorothiazide in essential hypertension: a double-blind crossover study in known responders to a standard combination.

Authors:  Y Lacourcière; L Poirier; P Provencher; P H Guivarc'h
Journal:  Br J Clin Pharmacol       Date:  1991-07       Impact factor: 4.335

Review 9.  Enalapril. A reappraisal of its pharmacology and therapeutic use in hypertension.

Authors:  P A Todd; K L Goa
Journal:  Drugs       Date:  1992-03       Impact factor: 9.546

10.  High prevalence of persistent cough with angiotensin converting enzyme inhibitors in Chinese.

Authors:  K S Woo; M G Nicholls
Journal:  Br J Clin Pharmacol       Date:  1995-08       Impact factor: 4.335

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.